Extracellular Acetylated Histone 3.3 Induces Inflammation and Lung Tissue Damage

Extracellular histones, part of the protein group known as damage-associated molecular patterns (DAMPs), are released from damaged or dying cells and can instigate cellular toxicity. Within the context of chronic obstructive pulmonary disease (COPD), there is an observed abundance of extracellular histone H3.3, indicating potential pathogenic implications. Notably, histone H3.3 is often found hyperacetylated (AcH3.3) in the lungs of COPD patients. Despite these observations, the specific role of these acetylated histones in inducing pulmonary tissue damage in COPD remains unclear. To investigate AcH3.3’s impact on lung tissue, we administered recombinant histones (rH2A, rH3.3, and rAcH3.3) or vehicle solution to mice via intratracheal instillation. After 48 h, we evaluated the lung toxicity damage and found that the rAcH3.3 treated animals exhibited more severe lung tissue damage compared to those treated with non-acetylated H3.3 and controls. The rAcH3.3 instillation resulted in significant histological changes, including alveolar wall rupture, epithelial cell damage, and immune cell infiltration. Micro-CT analysis confirmed macroscopic structural changes. The rAcH3.3 instillation also increased apoptotic activity (cleavage of caspase 3 and 9) and triggered acute systemic inflammatory marker activation (TNF-α, IL-6, MCP-3, or CXCL-1) in plasma, accompanied by leukocytosis and lymphocytosis. Confocal imaging analysis confirmed lymphocytic and monocytic/macrophage lung infiltration in response to H3.3 and AcH3.3 administration. Taken together, our findings implicate extracellular AcH3.3 in inducing cytotoxicity and acute inflammatory responses, suggesting its potential role in promoting COPD-related lung damage progression.

[1]  Q. Geng,et al.  HDAC3 promotes macrophage pyroptosis via regulating histone deacetylation in acute lung injury , 2023, iScience.

[2]  C. Hermenegildo,et al.  Extracellular Histones Activate Endothelial NLRP3 Inflammasome and are Associated with a Severe Sepsis Phenotype , 2022, Journal of inflammation research.

[3]  Wenxin Wang,et al.  Role of Histone Post-Translational Modifications in Inflammatory Diseases , 2022, Frontiers in Immunology.

[4]  Merav D Shmueli,et al.  Histone degradation by the proteasome regulates chromatin and cellular plasticity , 2021, The FEBS journal.

[5]  F. Martinez,et al.  Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease , 2020, American journal of respiratory and critical care medicine.

[6]  A. Birukova,et al.  Extracellular histones in lung dysfunction: a new biomarker and therapeutic target? , 2020, Pulmonary circulation.

[7]  S. De Flora,et al.  Inhalation exposure to cigarette smoke and inflammatory agents induces epigenetic changes in the lung , 2020, Scientific Reports.

[8]  A. Bonev,et al.  Extracellular histones induce calcium signals in the endothelium of resistance-sized mesenteric arteries and cause loss of endothelium-dependent dilation. , 2019, American journal of physiology. Heart and circulatory physiology.

[9]  G. Criner,et al.  Chronic Obstructive Pulmonary Disease: Evaluation and Management. , 2019, The Medical clinics of North America.

[10]  Wei Huang,et al.  Biology, role and therapeutic potential of circulating histones in acute inflammatory disorders , 2018, Journal of cellular and molecular medicine.

[11]  E. Evangelou,et al.  Gender-specific estimates of COPD prevalence: a systematic review and meta-analysis , 2018, International journal of chronic obstructive pulmonary disease.

[12]  P. Jiang,et al.  Extracellular histones are clinically relevant mediators in the pathogenesis of acute respiratory distress syndrome , 2017, Respiratory Research.

[13]  I. Rahman,et al.  Gene expression profiling of epigenetic chromatin modification enzymes and histone marks by cigarette smoke: implications for COPD and lung cancer. , 2016, American journal of physiology. Lung cellular and molecular physiology.

[14]  S. Zeerleder,et al.  Extracellular histones, cell-free DNA, or nucleosomes: differences in immunostimulation , 2016, Cell Death & Disease.

[15]  K. Hartshorn,et al.  Histones as mediators of host defense, inflammation and thrombosis. , 2016, Future microbiology.

[16]  F. Mohamed,et al.  The extensor carpi ulnaris pseudolesion: evaluation with microCT, histology, and MRI , 2015, Skeletal Radiology.

[17]  Jovilė Raudoniūtė,et al.  Novel aspects of pathogenesis and regeneration mechanisms in COPD , 2015, International journal of chronic obstructive pulmonary disease.

[18]  E. Ford Hospital discharges, readmissions, and ED visits for COPD or bronchiectasis among US adults: findings from the nationwide inpatient sample 2001-2012 and Nationwide Emergency Department Sample 2006-2011. , 2015, Chest.

[19]  D. Tang,et al.  Release and activity of histone in diseases , 2014, Cell Death and Disease.

[20]  H. Anders,et al.  Extracellular histones in tissue injury and inflammation , 2014, Journal of Molecular Medicine.

[21]  I. Rahman,et al.  Cigarette smoke induces distinct histone modifications in lung cells: implications for the pathogenesis of COPD and lung cancer. , 2014, Journal of proteome research.

[22]  Oscar Perez-Leal,et al.  Histone 3.3 participates in a self-sustaining cascade of apoptosis that contributes to the progression of chronic obstructive pulmonary disease. , 2013, American journal of respiratory and critical care medicine.

[23]  P. Bray,et al.  Erosive Arthritis and Hepatic Granuloma Formation Induced by Peptidoglycan Polysaccharide in Rats Is Aggravated by Prasugrel Treatment , 2013, PloS one.

[24]  Yie Yang,et al.  Expression level of histone deacetylase 2 correlates with occurring of chronic obstructive pulmonary diseases , 2013, Molecular Biology Reports.

[25]  V. Kim,et al.  Chronic bronchitis and chronic obstructive pulmonary disease. , 2013, American journal of respiratory and critical care medicine.

[26]  N. Zhang,et al.  Circulating histones are mediators of trauma-associated lung injury. , 2013, American journal of respiratory and critical care medicine.

[27]  M. Rico,et al.  Prasugrel Metabolites Inhibit Neutrophil Functions , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[28]  Deepti Malhotra,et al.  Heightened endoplasmic reticulum stress in the lungs of patients with chronic obstructive pulmonary disease: the role of Nrf2-regulated proteasomal activity. , 2009, American journal of respiratory and critical care medicine.

[29]  P. Barnes Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease. , 2009, Proceedings of the American Thoracic Society.

[30]  Jun Xu,et al.  Extracellular histones are major mediators of death in sepsis , 2009, Nature Medicine.

[31]  P. Barnes Histone deacetylase-2 and airway disease , 2009, Therapeutic advances in respiratory disease.

[32]  A. Gunjan,et al.  Histone levels are regulated by phosphorylation and ubiquitylation dependent proteolysis , 2009, Nature Cell Biology.

[33]  P. Barnes,et al.  Role of HDAC2 in the pathophysiology of COPD. , 2009, Annual review of physiology.

[34]  Hongwei Yao,et al.  Current Perspectives on Role of Chromatin Modifications and Deacetylases in Lung Inflammation in COPD , 2009, COPD.

[35]  P. Barnes Chronic Obstructive Pulmonary Disease: A Growing but Neglected Global Epidemic , 2007, PLoS medicine.

[36]  I. Sainz,et al.  Amelioration of inflammation, angiogenesis and CTGF expression in an arthritis model by a TSP1‐derived peptide treatment , 2007, Journal of cellular physiology.

[37]  D. Tang,et al.  Apoptotic Release of Histones from Nucleosomes* , 2002, The Journal of Biological Chemistry.

[38]  C. Allis,et al.  The language of covalent histone modifications , 2000, Nature.

[39]  C Hermans,et al.  Lung epithelium-specific proteins: characteristics and potential applications as markers. , 1999, American journal of respiratory and critical care medicine.

[40]  J. Zlatanova,et al.  Cytoplasmic pool of histone H1 in mammalian cells. , 1990, Journal of cell science.

[41]  R. Crystal,et al.  Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. , 1986, Journal of applied physiology.

[42]  E. Ford,et al.  Total and state-specific medical and absenteeism costs of COPD among adults aged ≥ 18 years in the United States for 2010 and projections through 2020. , 2015, Chest.

[43]  M. Duerden Prevention of death in COPD. , 2007, The New England journal of medicine.